NYSEAMERICAN:ELMD

Electromed - ELMD Stock Forecast, Price & News

$10.25

-0.06 (-0.58%)

(As of 09/30/2022 12:00 AM ET)

Add

Compare

Today's Range: $10.25
▼
$11.15
50-Day Range: N/A
52-Week Range: $8.75
▼
$13.46

Volume: 18,371 shs
Average Volume: 10,984 shs
Market Capitalization: $86.87 million

P/E Ratio: 41.00
Dividend Yield: N/A
Price Target: $17.83

Electromed MarketRank™ Forecast

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 74.0% Upside
$17.83 Price Target
Short Interest: Bearish
0.85% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.09
Based on 2 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 51.61%
From $0.31 to $0.47 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.46 out of 5 stars

3.5

Analyst's Opinion

Consensus Rating
Electromed has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $17.83, Electromed has a forecasted upside of 74.0% from its current price of $10.25.
Amount of Analyst Coverage
Electromed has only been the subject of 3 research reports in the past 90 days.

2.0

Short Interest

Percentage of Shares Shorted
0.85% of the float of Electromed has been sold short.
Short Interest Ratio / Days to Cover
Electromed has a short interest ratio ("days to cover") of 4.6.
Change versus previous month
Short interest in Electromed has recently increased by 26.34%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
Electromed does not currently pay a dividend.
Dividend Growth
Electromed does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for ELMD.

1.7

News and Social Media Coverage

News Sentiment
Electromed has a news sentiment score of 0.09. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.83 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 2 news articles for Electromed this week, compared to 1 article on an average week.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Electromed insiders have not sold or bought any company stock.
Percentage Held by Insiders
26.70% of the stock of Electromed is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
Only 39.67% of the stock of Electromed is held by institutions.

3.1

Earnings and Valuation

Earnings Growth
Earnings for Electromed are expected to grow by 51.61% in the coming year, from $0.31 to $0.47 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Electromed is 41.00, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 113.68.
Price to Earnings Ratio vs. Sector
The P/E ratio of Electromed is 41.00, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 78.93.
Price to Earnings Growth Ratio
Electromed has a PEG Ratio of 4.16. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Electromed has a P/B Ratio of 2.73. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Electromed (NYSEAMERICAN:ELMD) Stock

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products primarily to home health care and institutional markets for patients with bronchiectasis, cystic fibrosis, and neuromuscular diseases. It markets its products primarily to physicians and health care providers, as well as directly to patients. The company was incorporated in 1992 and is headquartered in New Prague, Minnesota.

Receive ELMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Electromed and its competitors with MarketBeat's FREE daily newsletter.

ELMD Stock News Headlines

October 1, 2022 | americanbankingnews.com

Short Interest in Electromed, Inc. (NYSEAMERICAN:ELMD) Grows By 26.3%

September 20, 2022 | benzinga.com

PFPI: Tide Turning on Use of Wood-Burning for Renewable Energy in Europe - Benzinga

September 19, 2022 | benzinga.com

Frank Stella Enters The Metaverse - Benzinga

September 18, 2022 | benzinga.com

Mark Cuban Thinks Elon Musk's Question About Inflation Is 'Ridiculous', Has This To Say Instead - Benzinga

September 16, 2022 | benzinga.com

This Company's Medical Device Could Be A Game Changer For The Military - electroCore (NASDAQ:ECOR), BioSig Technologies (NASDAQ:BSGM) - Benzinga

September 15, 2022 | businesswire.com

Global Airway Management Pipeline Report 2022: Stages of Development, Regulatory Path, Estimated Approval Date, Ongoing Clinical Trials and Key Companies - ResearchAndMarkets.com - Business Wire

September 13, 2022 | benzinga.com

Electromed (AMEX:ELMD) – Electromed Earnings Perspective: Return On Capital Employed - Benzinga

September 13, 2022 | msn.com

Electromed Earnings Perspective: Return On Capital Employed

September 8, 2022 | seekingalpha.com

Electromed, Inc.: 2 Potential Paths To A Very Attractive Return

September 5, 2022 | seekingalpha.com

Summers Value Partners Q2 2022 Investor Letter - Seeking Alpha

August 29, 2022 | globenewswire.com

Global Neuromodulation Devices Market Anticipated to Grow at a CAGR of 19.7% by 2026, Despite COVID-19 Pandemic Crisis | Report by Research Dive - GlobeNewswire

August 26, 2022 | stocknews.com

EAR: Should You Buy Eargo After the FDA Ruling on Hearing Aids? - StockNews.com

August 26, 2022 | finance.yahoo.com

Nortech Systems Announces Patent for Flexible Faraday Cage Printed Circuit Board and Cable - Yahoo Finance

August 25, 2022 | businesswire.com

Nortech Systems Announces Patent for Flexible Faraday Cage Printed Circuit Board and Cable - Business Wire

August 24, 2022 | investing.com

Electromed Misses Q2 EPS by 2c By Investing.com - Investing.com

August 23, 2022 | finance.yahoo.com

Electromed, Inc. Announces Fiscal 2022 Fourth Quarter and Full Year Financial Results

August 23, 2022 | au.investing.com

Electromed Misses Q2 EPS by 2c By Investing.com - Investing.com Australia

August 23, 2022 | businesswire.com

Electromed, Inc. Announces Fiscal 2022 Fourth Quarter and Full Year Financial Results - Business Wire

August 10, 2022 | businesswire.com

Nortech Systems Announces 2022 Second Quarter Results - Business Wire

August 8, 2022 | finance.yahoo.com

The Global Mucus Clearance Devices Market is expected to grow by $ 193.28 mn during 2022-2026, accelerating at a CAGR of 6.22% during the forecast period - Yahoo Finance

August 3, 2022 | finance.yahoo.com

BizVibe Adds New Company Insights for 10,000+ Navigational, Measuring, Electromedical, and Control Instrument Companies | Risk Evaluation | Regional Analysis | Similar Companies | Financials and Management Team - Yahoo Finance

August 2, 2022 | businesswire.com

Electromed, Inc. Schedules its Fourth Quarter and Fiscal 2022 Financial Results Conference Call for August 23, 2022 at 5:00 p.m. ET - Business Wire

July 25, 2022 | businesswire.com

Electromed, Inc. Announces Election of Andrew Summers as Additional Independent Director - Business Wire

July 25, 2022 | finance.yahoo.com

Electromed, Inc. Announces Election of Andrew Summers as Additional Independent Director

July 20, 2022 | benzinga.com

Nortech Systems to Report Fiscal Second Quarter Financial Results and Hold Conference Call on August 10, - Benzinga

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive ELMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Electromed and its competitors with MarketBeat's FREE daily newsletter.

ELMD Company Calendar

Last Earnings: 8/23/2022
Today: 10/02/2022
Fiscal Year End: 6/30/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSEAMERICAN
Industry: Electromedical equipment
Sub-Industry: N/A
Sector: Medical
Current Symbol: NYSEAMERICAN:ELMD
Previous Symbol: NYSEMKT:ELMD
CUSIP: N/A
CIK: 1488917
Web: smartvest.com
Phone: (952) 758-9299
Fax: 866-758-5077
Employees: 132
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $17.83
High Stock Price Forecast: $20.00
Low Stock Price Forecast: $13.50
Forecasted Upside/Downside: +74.0%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 4 Analysts

Profitability

EPS (Most Recent Fiscal Year): $0.25
Trailing P/E Ratio: 41.00
Forward P/E Ratio: 33.06
P/E Growth: 4.16
Net Income: $2.36 million
Net Margins: 6.00%
Pretax Margin: 8.06%
Return on Equity: 6.94%
Return on Assets: 6.12%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 6.74
Quick Ratio: 6.32

Sales & Book Value

Annual Sales: $35.76 million
Price / Sales: 2.43
Cash Flow: $0.27 per share
Price / Cash Flow: 37.45
Book Value: $3.75 per share
Price / Book: 2.73

Miscellaneous

Outstanding Shares: 8,475,000
Free Float: 6,282,000
Market Cap: $86.87 million
Optionable: Not Optionable
Beta: 0.65

Key Executives

Ms. Kathleen S. Skarvan (Age 66)
CEO, Pres & Director
Comp: $701.64k

Ms. Michelle C. Wirtz (Age 39)
Interim CFO, Treasurer, Sec. & Corp. Controller

Ms. Diane M. Kaufman
VP of HR

Mr. Christopher G. Holland (Age 53)
Chief Commercial Officer

Mr. William J. George (Age 73)
Sec.

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

ELMD Stock - Frequently Asked Questions

Should I buy or sell Electromed stock right now?: 4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Electromed in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ELMD shares.
View ELMD analyst ratings or view top-rated stocks.
What is Electromed's stock price forecast for 2022?: 4 brokers have issued 12 month price objectives for Electromed's shares. Their ELMD share price forecasts range from $13.50 to $20.00. On average, they anticipate the company's stock price to reach $17.83 in the next year. This suggests a possible upside of 74.0% from the stock's current price.
View analysts price targets for ELMD or view top-rated stocks among Wall Street analysts.
How have ELMD shares performed in 2022?: Electromed's stock was trading at $12.95 on January 1st, 2022. Since then, ELMD stock has decreased by 20.8% and is now trading at $10.25.
View the best growth stocks for 2022 here.
Are investors shorting Electromed?: Electromed saw a increase in short interest in September. As of September 15th, there was short interest totaling 51,800 shares, an increase of 26.3% from the August 31st total of 41,000 shares. Based on an average daily volume of 11,300 shares, the days-to-cover ratio is presently 4.6 days. Approximately 0.9% of the shares of the stock are sold short.
View Electromed's Short Interest.
How were Electromed's earnings last quarter?: Electromed, Inc. (NYSEAMERICAN:ELMD) released its earnings results on Tuesday, August, 23rd. The medical equipment provider reported $0.04 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.08 by $0.04. Electromed had a net margin of 6.00% and a trailing twelve-month return on equity of 6.94%.

What other stocks do shareholders of Electromed own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Electromed investors own include AbbVie (ABBV), TransEnterix (TRXC), AT&T (T), ACADIA Pharmaceuticals (ACAD), CRISPR Therapeutics (CRSP), Enphase Energy (ENPH), Inseego (INSG), Novavax (NVAX), NVIDIA (NVDA) and Pfizer (PFE).
What is Electromed's stock symbol?: Electromed trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "ELMD."
How do I buy shares of Electromed?: Shares of ELMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Electromed's stock price today?: One share of ELMD stock can currently be purchased for approximately $10.25.
How much money does Electromed make?: Electromed (NYSEAMERICAN:ELMD) has a market capitalization of $86.87 million and generates $35.76 million in revenue each year. The medical equipment provider earns $2.36 million in net income (profit) each year or $0.25 on an earnings per share basis.
How many employees does Electromed have?: The company employs 132 workers across the globe.
How can I contact Electromed?: Electromed's mailing address is 500 6th Ave NW, NEW PRAGUE, MN 56071-1134, United States. The official website for the company is smartvest.com. The medical equipment provider can be reached via phone at (952) 758-9299, via email at investorrelations@electromed.com, or via fax at 866-758-5077.

This page (NYSEAMERICAN:ELMD) was last updated on 10/2/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Electromed - ELMD Stock Forecast, Price & News

Electromed MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month